By Reuters Staff
1 Min Read
March 17 (Reuters) - Contract manufacturer Catalent said on Wednesday it was expanding its partnership with Johnson & Johnson to raise the manufacturing capacity at its plant in Anagni, Italy for large-scale supply of J&J’s COVID-19 vaccine.
Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva